Silver Book Fact

The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually– $5.12 billion in additional medical care expenditures and $360 million in informal care costs.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The average cost in 2004 per diabetic retinopathy patient age 40 to 64 using outpatient services was $629. The average cost per patient 65 years and older was $463.  
  • Estimated Specific Prevalence Rates for AMD  
  • In 2001, approximately 420,000 diabetic retinopathy patients visited physicians or hospitals for treatment of their disease.  
  • Estimated Specific Prevalence Rates for AMD  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using inpatient services was $2,270. The average cost per patient 65 years and older was $4,929.